Cooper Companies (COO): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Cooper Companies ( COO) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.2%. By the end of trading, Cooper Companies fell 96 cents (-1%) to $94.94 on heavy volume. Throughout the day, two million shares of Cooper Companies exchanged hands as compared to its average daily volume of 401,000 shares. The stock ranged in price between $94.22-$97.50 after having opened the day at $96.25 as compared to the previous trading day's close of $95.90. Other companies within the Health Services industry that declined today were: USMD Holdings ( USMD), down 23%, NeuroMetrix ( NUROD), down 9.1%, Retractable Technologies ( RVP), down 7.1%, and Strategic Diagnostics ( SDIX), down 5.3%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Cooper Companies, Inc. engages in the provision of medical devices for healthcare professionals worldwide. Cooper Companies has a market cap of $4.63 billion and is part of the health care sector. The company has a P/E ratio of 20.2, above the S&P 500 P/E ratio of 17.7. Shares are up 36% year to date as of the close of trading on Thursday. Currently there are six analysts that rate Cooper Companies a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, SunLink Health Systems ( SSY), up 16.7%, Response Genetics ( RGDX), up 12.2%, Uroplasty ( UPI), up 11.8%, and Alphatec Holdings ( ATEC), up 9.6%, were all gainers within the health services industry with Aetna ( AET) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

Good News Is Actually Good for the Stock Market: Market Recon

Market Recon: Banks Like JPMorgan Are Looking Sloppy, China Seems Ugly -- What Else Could Go Wrong?

Market Recon: With Snap, Only a Significant Discount Would Do for Me

Analyst Says Cooper is Poised to Gain Market Share

Water-Logged And Getting Wetter: Cooper Companies (COO)